| |
|
|
| Name: |
Fairmount Funds Management LLC |
| City: |
no |
| State: |
no |
| Zip: |
no |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
20 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
AXSM |
Axsome Therapeutics, Inc. |
1 |
- |
$71.71 |
$187,839,000 |
2,360,077 |
19.85% |
24,210,000 |
18,839 |
6.321 |
N/A |
|
|
IMGN |
Immunogen Inc |
2 |
- |
$31.23 |
$175,812,000 |
5,929,592 |
18.58% |
81,709,000 |
0 |
2.686 |
Drug Manufacturers - ... |
|
|
NUVL |
Nuvalent, Inc. |
3 |
- |
$0.00 |
$141,633,000 |
1,924,626 |
14.96% |
28,923,000 |
-527,193 |
3.378 |
N/A |
|
|
APGE |
Apogee Therapeutics, Inc. |
4 |
- |
$47.13 |
$82,176,000 |
2,941,176 |
8.68% |
19,529,000 |
0 |
7.909 |
N/A |
|
|
RYZB |
Rayzebio, Inc. |
5 |
- |
$62.49 |
$77,459,000 |
1,245,929 |
8.18% |
50,333,000 |
24,025 |
2.05 |
N/A |
|
|
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
6 |
- |
$17.88 |
$50,572,000 |
2,883,221 |
5.34% |
7,589,000 |
408,660 |
8.55 |
N/A |
|
|
ARGX |
Argenx Se |
7 |
- |
$372.80 |
$42,952,000 |
112,903 |
4.54% |
1,779,000 |
29,156 |
0.24 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
8 |
- |
$12.88 |
$29,830,000 |
1,369,623 |
3.15% |
8,820,000 |
0 |
3.021 |
N/A |
|
|
ELVN |
Enliven Therapeutics Ord Shs |
9 |
- |
$0.00 |
$29,498,000 |
2,131,369 |
3.12% |
383,000 |
0 |
6.024 |
N/A |
|
|
ATXS |
Astria Therapeutics, Inc |
10 |
- |
$9.00 |
$27,296,000 |
3,554,129 |
2.88% |
13,112,000 |
1,652,732 |
14.328 |
N/A |
|
|
COGT |
Cogent Biosciences, Inc. |
11 |
- |
$6.02 |
$20,927,000 |
3,558,975 |
2.21% |
-13,773,000 |
0 |
4.501 |
N/A |
|
|
DNTH |
Dianthus Therapeutics Ord Shs |
12 |
- |
$0.70 |
$20,056,000 |
1,928,503 |
2.12% |
-6,307,000 |
0 |
13.013 |
N/A |
|
|
MRUS |
Merus Nv |
13 |
- |
$45.04 |
$19,724,000 |
717,254 |
2.08% |
-24,638,000 |
-1,164,091 |
1.681 |
N/A |
|
|
TYRA |
Tyra Biosciences, Inc. |
14 |
- |
$0.00 |
$19,298,000 |
1,393,329 |
2.04% |
112,000 |
0 |
3.376 |
N/A |
|
|
TERN |
Terns Pharmaceuticals, Inc. |
15 |
- |
$4.91 |
$13,240,000 |
2,040,000 |
1.4% |
2,979,000 |
0 |
3.657 |
N/A |
|
|
AGLE |
Aeglea Biotherapeutics, Inc. |
16 |
- |
$0.60 |
$8,144,000 |
378,421 |
0.86% |
3,508,000 |
0 |
0.619 |
N/A |
|
|
TRVI |
Trevi Therapeutics, Inc. |
20 |
Closed |
$0.00 |
$0 |
0 |
0% |
-11,256,000 |
-5,163,287 |
0 |
N/A |
|
|
SLNO |
Soleno Therapeutics Inc |
17 |
Closed |
$0.16 |
$0 |
0 |
0% |
-33,714,000 |
-1,142,473 |
0 |
N/A |
|
|
IMVT |
Immunovant Inc |
19 |
Closed |
$0.00 |
$0 |
0 |
0% |
-28,793,000 |
-750,000 |
0 |
N/A |
|
|
DBVT |
DBV Technologies SA |
18 |
Closed |
$0.68 |
$0 |
0 |
0% |
-9,222,000 |
-6,781,150 |
0 |
N/A |
|
